New evidence-based guidelines from the American College of Chest Physicians (ACCP) recommend considering individual patients' risk of thrombosis when deciding for or against the use of preventive ...
Please provide your email address to receive an email when new articles are posted on . Until recently, orthopedic surgeons lacked specialty-specific recommendations for preventing venous ...
“Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines” offers more than 600 recommendations for the diagnosis, ...
Am J Health Syst Pharm. 2006;63(24):2448-2450. Q: It has become very common to use expensive low-molecular-weight heparins (LMWHs) for prophylaxis of deep venous thrombosis (DVT) in hospitalized ...
Combating patient noncompliance with DVT prophylaxis Successful DVT prophylaxis with pharmacologic agents and adjunctive treatment modalities depends on both consistency and accuracy. Before deciding ...
The post-operative risk period for venous thromboembolism is still unknown and indications for post-discharge prophylaxis are controversial. Detectable thrombus formation after hip arthroplasty is ...
The FDA has approved a new indication for apixaban (Eliquis), the anticoagulant drug manufactured by Bristol-Myers Squibb and Pfizer. The new indication is for the prophylaxis of deep vein thrombosis ...
Rivaroxaban (Xarelto; Bayer/Janssen) has gained an additional indication, this time for venous thromboembolism (VTE) prophylaxis in acutely ill hospitalized patients at increased risk for ...
Stakeholders concurred that the occurrence of VTE events is a significant public health concern. According to Ralph J. Riello III, PharmD, “It is a problem often that hospitals do not know that they ...
The paper discusses guidelines for the prevention of venous thromboembolism (VTE), with particular emphasis on the use of mechanical methods. Mechanical prophylaxis of VTE does not involve the risk of ...
There is broad consensus regarding the importance of thromboprophylaxis in hospitalized patients with cancer, including prolonged prophylaxis in high-risk surgical patients. Prophylaxis is not ...
antithrombin III [human] Thrombate III inj Hereditary antithrombin III (AT-III) deficiency in surgical or obstetrical procedures and thromboembolism Infuse over 10–20mins. Dose (units required) = ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results